G71.3
Mitochondrial myopathy, not elsewhere classified
Clinical Classification Guidelines
Excludes Type 1
- Kearns-Sayre syndrome (H49.81)
- Leber's disease (H47.21)
- Leigh's encephalopathy (G31.82)
- mitochondrial metabolism disorders (E88.4.-)
- Reye's syndrome (G93.7)
Medical Intelligence & Overview
Mitochondrial myopathy is a rare type of muscular disorder caused by problems in the mitochondria, the energy-producing structures within cells. When the mitochondria do not function correctly, muscles can become weak and fatigued. This condition can affect various muscles in the body, leading to a range of physical difficulties. Because mitochondrial myopathy can be complex and vary widely from person to person, understanding its aspects can help patients and caregivers better navigate diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations passed down from parents Inherited mitochondrial DNA abnormalities Mutations affecting nuclear DNA that influence mitochondrial function Occasionally, environmental factors or multifactorial causes that impact mitochondrial health
Key Symptoms: Muscle weakness and fatigue, especially after activity Difficulty with coordination and balance Muscle pain or cramps Problems with eye movements, leading to issues like ptosis (drooping eyelid) Respiratory difficulties due to weakened respiratory muscles Hearing loss or deafness Swallowing problems (dysphagia) Exercise intolerance In some cases, multisystem involvement affecting the brain, heart, and other tissues
Diagnostic & Treatment
Diagnosis Path: Blood tests measuring muscle enzyme levels Electromyography (EMG) to evaluate muscle activity Muscle biopsy to examine tissue under a microscope for characteristic mitochondrial abnormalities Genetic testing to identify specific mutations in mitochondrial or nuclear DNA Imaging studies such as MRI to assess muscle and brain involvement Exercise testing to evaluate muscle endurance and fatigability
Treatment Protocols: Nutritional support and dietary modifications Physical therapy to maintain muscle strength and flexibility Assistive devices to aid mobility and daily activities Medications to manage specific symptoms, such as pain or cardiac issues Avoidance of mitochondrial toxins like certain medications or environmental toxins Supplements such as coenzyme Q10, L-carnitine, and antioxidants, though their effectiveness varies Monitoring and managing multisystem involvement with a multidisciplinary healthcare team
Clinical Advice & FAQs
Billing Guidance
Is G71.3 a billable ICD-10 code?
Yes, G71.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G71.3?
Clinical documentation must specify the nature of Mitochondrial myopathy, not elsewhere classified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference